CIPLA2019-10-012019-12-31in-bse-fin:OneOperatingExpenses01Member CIPLA2019-10-012019-12-31in-bse-fin:FourOperatingExpenses01Member CIPLA2019-10-012019-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member CIPLA2019-10-012019-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member CIPLA2019-10-012019-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member CIPLA2019-10-012019-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares CIPLA 2019-04-01 2020-03-31 2020-01-06 INR Crores Third quarter Single segment Pharmaceutical 2019-10-01 2019-12-31 Unaudited Standalone 29262000000.00 732800000.00 29994800000.00 6953000000.00 3703400000.00 214800000.00 4741100000.00 95500000.00 1431400000.00 9280300000.00 26419500000.00 3575300000.00 0.00 3575300000.00 611000000.00 142100000.00 753100000.00 0.00 2822200000.00 0.00 0.00 0.00 0.00 2822200000.00 -85800000.00 2736400000.00 0.00 0.00 1612500000.00 2 3.50 3.50 0.00 0.00 3.50 3.50 Due to space constraints the notes cannot be provided in the XBRL utility. Please refer the PDF file of Financial Results uploaded yesterday on 05 February 2020 for notes to accounts Single segment 2019-04-01 2019-12-31 Unaudited Standalone 95257100000.00 4794400000.00 100051500000.00 22328100000.00 10184200000.00 -1496400000.00 14338000000.00 268100000.00 4393600000.00 27478300000.00 77493900000.00 22557600000.00 0.00 22557600000.00 4624000000.00 797600000.00 5421600000.00 0.00 17136000000.00 0.00 0.00 0.00 0.00 17136000000.00 -485300000.00 16650700000.00 0.00 0.00 1612500000.00 2 21.26 21.23 0.00 0.00 21.26 21.23 Other Expenses 9280300000.00 Other Expenses 27478300000.00